105 related articles for article (PubMed ID: 16794439)
1. Treatment of nonexudative (dry) age-related macular degeneration.
Donaldson MJ; Pulido JS
Curr Opin Ophthalmol; 2006 Jun; 17(3):267-74. PubMed ID: 16794439
[TBL] [Abstract][Full Text] [Related]
2. Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysis.
Pulido JS;
Trans Am Ophthalmol Soc; 2002; 100():85-106; discussion 106-7. PubMed ID: 12545682
[TBL] [Abstract][Full Text] [Related]
3. Haemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular form.
Rencová E; Bláha M; Studnička J; Blažek M; Bláha V; Dusová J; Malý J; Kyprianou G; Vašátko T; Langrová H
Acta Ophthalmol; 2011 Aug; 89(5):463-71. PubMed ID: 20102350
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
[TBL] [Abstract][Full Text] [Related]
5. Anecortave acetate for the treatment of exudative age-related macular degeneration--a review of clinical outcomes.
Russell SR; Hudson HL; Jerdan JA;
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S79-90. PubMed ID: 17240260
[TBL] [Abstract][Full Text] [Related]
6. Nutritional supplementation and age-related macular degeneration.
Olson JH; Erie JC; Bakri SJ
Semin Ophthalmol; 2011 May; 26(3):131-6. PubMed ID: 21609225
[TBL] [Abstract][Full Text] [Related]
7. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
Richer S; Devenport J; Lang JC
Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
[TBL] [Abstract][Full Text] [Related]
8. Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.
Complications of Age-Related Macular Degeneration Prevention Trial Research Group
Ophthalmology; 2006 Nov; 113(11):1974-86. PubMed ID: 17074563
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine.
Klingel R; Fassbender C; Fassbender T; Göhlen B
Transfus Apher Sci; 2003 Aug; 29(1):71-84. PubMed ID: 12877897
[TBL] [Abstract][Full Text] [Related]
10. [Macular pigment and age-related macular degeneration. Clinical implications].
Haddad WM; Souied E; Coscas G; Soubrane G
Bull Soc Belge Ophtalmol; 2006; (301):15-22. PubMed ID: 17552428
[TBL] [Abstract][Full Text] [Related]
11. Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration.
Landa G; Butovsky O; Shoshani J; Schwartz M; Pollack A
Curr Eye Res; 2008 Nov; 33(11):1011-3. PubMed ID: 19085384
[TBL] [Abstract][Full Text] [Related]
12. [Age related macular degeneration].
Helgadóttir G; Jónasson F; Sigurdsson H; Magnússon KP; Stefánsson E
Laeknabladid; 2006 Oct; 92(10):685-96. PubMed ID: 17062902
[TBL] [Abstract][Full Text] [Related]
13. [Drusen in Bruch's membrane. Their significance for the pathogenesis and therapy of age-associated macular degeneration].
Pauleikhoff D
Ophthalmologe; 1992 Oct; 89(5):363-86. PubMed ID: 1304217
[TBL] [Abstract][Full Text] [Related]
14. Age related macular degeneration--should your patients be taking additional supplements?
Jones AA
Aust Fam Physician; 2007 Dec; 36(12):1026-8. PubMed ID: 18075628
[TBL] [Abstract][Full Text] [Related]
15. Treatment of neovascular age-related macular degeneration: past, present and future directions.
Smith BT; Joseph DP; Grand MG
Curr Opin Ophthalmol; 2007 May; 18(3):240-4. PubMed ID: 17435433
[TBL] [Abstract][Full Text] [Related]
16. [Age-related macular degeneration; therapeutic options].
La Heij EC; Liem AT; Hendrikse F
Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1390-7. PubMed ID: 11494688
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of macular grid photocoagulation in treatment of nonexudative age-related macular degeneration.
Nili-Ahmadabadi M; Espandar L; Mansoori MR; Karkhane R; Riazi M; Ardestani E
Arch Iran Med; 2007 Jan; 10(1):14-9. PubMed ID: 17198447
[TBL] [Abstract][Full Text] [Related]
18. Preclinical efficacy of anecortave acetate.
Clark AF
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S41-8. PubMed ID: 17240256
[TBL] [Abstract][Full Text] [Related]
19. [Is there a drug therapy for age-related macular degeneration?--current status and new therapeutic approaches].
Augustin AJ; Offermann I
Klin Monbl Augenheilkd; 2008 Jun; 225(6):555-63. PubMed ID: 18516776
[TBL] [Abstract][Full Text] [Related]
20. Preliminary analysis of the final multicenter investigation of rheopheresis for age related macular degeneration (AMD) trial (MIRA-1) results.
Pulido JS; Winters JL; Boyer D
Trans Am Ophthalmol Soc; 2006; 104():221-31. PubMed ID: 17471343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
